04/23/2025
7:19 PM | BlackRock, Inc. (Filed by)
Castle Biosciences (Subject)
| Form SCHEDULE 13G/A | |
04/14/2025
2:34 PM | Castle Biosciences (Subject)
Portolan Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
04/10/2025
3:07 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
10:43 AM | Castle Biosciences (Filer)
| Form DEF 14A | |
04/09/2025
10:45 AM | Castle Biosciences (Filer)
| Form DEFA14A | |
04/09/2025
10:47 AM | Castle Biosciences (Filer)
| Form ARS | |
04/08/2025
3:56 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2025
6:06 PM | Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
| Form 4/A | |
03/12/2025
3:30 PM | Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
| Form 4/A | |
03/06/2025
3:10 PM | Castle Biosciences (Issuer)
Stokes Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:28 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for CSTL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Castle Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
02/27/2025
3:10 PM | Castle Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
3:13 PM | Castle Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/24/2025
3:23 PM | Castle Biosciences (Issuer)
Stokes Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:25 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
8:33 PM | Castle Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/15/2025
3:57 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
5:58 AM | Castle Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
5:19 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:17 PM | Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:18 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
3:39 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:21 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
4:00 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
3:55 PM | Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
4:09 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:28 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:14 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
5:21 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
5:44 PM | Castle Biosciences (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
11/06/2024
3:21 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:32 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:33 PM | Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:34 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:49 PM | Castle Biosciences (Subject)
Juvenal Tobin W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
3:34 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
3:22 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
3:30 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:48 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:33 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:23 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad) Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade.
In 2023, it surged 239%. And in 2024, it soared another 171% on the year…
But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less? Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
09/13/2024
3:33 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:15 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
4:18 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
3:06 PM | Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:07 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:11 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:17 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
5:13 PM | Castle Biosciences (Issuer)
Stokes Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:14 PM | Castle Biosciences (Issuer)
Stokes Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:15 PM | Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:16 PM | Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:17 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:37 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2024
2:13 PM | Castle Biosciences (Subject)
Stokes Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
5:43 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4/A | |
07/16/2024
3:49 PM | Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:51 PM | Caple Kim (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Castle Biosciences (Subject)
| Form SC 13G/A | |
07/01/2024
3:45 PM | Castle Biosciences (Subject)
Oelschlager Kristen M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
4:23 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:52 PM | Aspinall Mara G. (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:21 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
3:40 PM | Castle Biosciences (Issuer)
Harrison Miles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:41 PM | Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:43 PM | Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:44 PM | Caple Kim (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:46 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:37 PM | Castle Biosciences (Issuer)
Olson Tiffany (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:18 PM | Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:10 PM | Castle Biosciences (Issuer)
Olson Tiffany (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:13 PM | Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Caple Kim (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:05 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:06 PM | Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:08 PM | Castle Biosciences (Issuer)
Harrison Miles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy CSTL Stock Free CSTL Stock Alerts